Add BrightSurf on Google Email

University of Utah Health


Within six families, a path to personalized treatment for an immune disorder

Researchers discovered a new class of common variable immunodeficiency disorder (CVID) caused by IKAROS gene mutations, enabling definitive genetic diagnosis and potential personalized treatment. The study found six unrelated families sharing similar symptoms and changes in the same gene, highlighting the need for early intervention.

SourceUniversity of Utah Health·JournalNew England Journal of Medicine·DateMar 16, 2016

Hidden in plain sight: Well-known drug could yield new treatment for herpes viruses

Scientists at University of Utah Health discovered that spironolactone, a medicine for heart failure, can also inhibit Epstein Barr virus by blocking a key step in viral infection. This finding has broader implications, suggesting that spironolactone could be developed into a new class of anti-herpesvirus drug.

SourceUniversity of Utah Health·JournalProceedings of the National Academy of Sciences·DateMar 14, 2016

Why online doctor ratings are good medicine

A new study found that openly sharing patient satisfaction metrics created a culture of empathy, communication, trust, and shared decision making between patients and providers at University of Utah Health Care. This led to improved patient outcomes and cultural change in healthcare.

SourceUniversity of Utah Health·JournalAcademic Medicine·DateDec 1, 2015

Study shows benefits of intensive blood pressure management

A study published in the New England Journal of Medicine found that lowering systolic blood pressure to less than 120 mmHg significantly reduced the risk of heart attack, stroke, and death in adults, especially those over 75. However, intensive treatment also increased the risk of hypotension, fainting, and acute kidney abnormalities.

SourceUniversity of Utah Health·JournalNew England Journal of Medicine·DateNov 9, 2015

How low to go for blood pressure? Lower target could affect millions of Americans

A new study suggests that lowering systolic blood pressure to 120 mmHg could benefit up to 16.8 million Americans, who meet specific eligibility criteria for intensive blood pressure management. The study found that this lower target could have a significant impact on reducing risk of heart failure, heart attack, and death.

SourceUniversity of Utah Health·JournalJournal of the American College of Cardiology·DateNov 9, 2015

Viruses thrive in big families, in sickness and in health

A study by the University of Utah Health found that households with children are more likely to experience viral infections throughout the year. On average, people in childless households were infected for 3-4 weeks, while those with one child were infected for 18 weeks, and those with six children were infected for up to 45 weeks.

SourceUniversity of Utah Health·JournalClinical Infectious Diseases·DateAug 5, 2015

Coordinated effort by health care facilities can prevent many hospital-acquired infections

Researchers developed a model to project number of CRE infections when hospitals work together to enhance infection controls, showing a 74% reduction compared to independent approach. The model highlights the importance of coordination and communication among facilities in preventing antibiotic-resistant infections.

SourceUniversity of Utah Health·JournalMMWR Morbidity and Mortality Weekly Report·DateAug 4, 2015

Health-care providers a major contributor to problem of antibiotic overuse

A study published in Annals of Internal Medicine found that 10% of health care providers write an antibiotic prescription for nearly every patient (95 percent or more) who walks in with a cold, bronchitis or other acute respiratory infection. This variation is driven by individual provider habits rather than differences in patient char...

SourceUniversity of Utah Health·JournalAnnals of Internal Medicine·DateJul 20, 2015

Genetic testing in kids is fraught with complications

The American Society of Human Genetics recommends genetic testing for children only when results could have an immediate impact on healthcare decisions. Predictive testing is particularly complicated and may affect family relationships and mental health. ASHG advises against direct-to-consumer DNA testing, especially in healthy children.

SourceUniversity of Utah Health·JournalAmerican Journal of Human Genetics·DateJul 2, 2015

Childhood cancer survivors more likely to claim social security support as adults

A recent study from Huntsman Cancer Institute found that childhood cancer survivors are more than five times as likely to be enrolled in federal social security disability assistance programs compared to individuals without a cancer history. The study identified survivor socio-demographic and treatment characteristics associated with a...

SourceUniversity of Utah Health·JournalJNCI Journal of the National Cancer Institute·DateApr 21, 2015

Dealing with death in deployment

A new University of Utah study found that exposure to killing and death while deployed is correlated with a 43% increased suicide risk compared to general deployment. The research suggests that seeing death and killing contributes to feelings of guilt, shame, regret, and negative self-perceptions.

SourceUniversity of Utah Health·JournalSuicide and Life-Threatening Behavior·DateApr 9, 2015

Rates of ADHD appear to decrease at higher altitudes

Researchers found that ADHD prevalence decreases substantially at higher elevations, correlating with increased dopamine levels. The study suggests that hypobaric hypoxia, a condition caused by lower oxygen levels at high altitudes, may serve as an environmental stressor and potentially protect against the disorder.

SourceUniversity of Utah Health·JournalJournal of Attention Disorders·DateApr 7, 2015

Identification of much-needed drug target against MRSA, gram-positive infections

Scientists at the University of Utah and Georgia have discovered a pharmacological target that could enable development of novel drugs against antibiotic-resistant pathogens, including MRSA. The target is based on a unique pathway for making heme, an essential iron-carrying molecule specific to Gram-positive bacteria.

SourceUniversity of Utah Health·JournalProceedings of the National Academy of Sciences·DateFeb 2, 2015